Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

Clinical Biochemistry

Volumn 42, Issue 9, 2009, Pages 791-795

  Tapan, Serkan ^a   Dogru, Teoman ^a   Tasci, Ilker ^a   Ercin, Cemal Nuri ^a   Ozgurtas, Taner ^a   Erbil, Mehmet Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Atherosclerosis; Bilirubin; Gilbert's syndrome; hs CRP; sCD40L; sP selectin

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CD40 LIGAND; PADGEM PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GILBERT DISEASE; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CD40 LIGAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GILBERT DISEASE; HUMANS; MALE; P-SELECTIN; YOUNG ADULT;

EID: 67349088999     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.02.005     Document Type: Article

References (49)

1. van Es H.H., Bout A., Liu J., et al. Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. Cytogenet. Cell Genet. 63 (1993) 114-116
2. Schwertner H.A., Jackson W.G., and Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery. Clin. Chem. 40 (1994) 18-23
3. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., and Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 250-255
4. Novotny L., and Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp. Biol. Med. 228 (2003) 568-571
5. Bulmer A.C., Blanchfield J.T., Toth I., Fassett R.G., and Coombes J.S. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199 (2008) 390-396
6. Mylonas C., and Kouretas D. Lipid peroxidation and tissue damage. In Vivo 13 (1999) 295-309
7. Schwertner H.A., and Vítek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198 (2008) 1-11
8. Phipps R.P. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6930-6932
9. Garlichs C.D., John S., Schmeisser A., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
10. Aukrust P., Müller F., Ueland T., Berget T., Aaser E., and Brunsvig A. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100 (1999) 614-620
11. Varo N., Vicent D., Libby P., et al. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation 107 (2003) 2664-2669
12. Schönbeck U., Varo N., Libby P., Buring J., and Ridker P.M. Soluble CD40L and cardiovascular risk in women. Circulation 104 (2001) 2266-2268
13. Wagner D.D. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb. Haemost. 70 (1993) 105-110
14. Lip G.Y., Blann A.D., Zarifis J., Beevers M., Lip P.L., and Beevers D.G. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J. Hypertens. 13 (1995) 1674-1678
15. Davì G., Romano M., Mezzetti A., et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 97 (1998) 953-957
16. Blann A.D., Dobrotova M., Kubisz P., and McCollum C.N. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb. Haemost. 74 (1995) 626-630
17. Shimomura H., Ogawa H., Arai H., et al. Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction. Am. J. Cardiol. 81 (1998) 397-400
18. Ridker P.M., Buring J.E., and Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 103 (2001) 491-495
19. Hirschfield G.M., and Alexander G.J. Gilbert's syndrome: an overview for clinical biochemists. Ann. Clin. Biochem. 43 (2006) 340-343
20. Friedewald W.T., Levy R., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
21. Varo N., Nuzzo R., Natal C., Libby P., and Schönbeck U. Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clin. Sci. 111 (2006) 341-347
22. Breimer L.H., Wannamethee G., Ebrahim S., and Shaper A.G. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin. Chem. 41 (1995) 1504-1508
23. Vítek L., Jirsa M., Brodanová M., et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160 (2002) 449-456
24. Schwertner H.A. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136 (1998) 383-387
25. Perlstein T.S., Pande R.L., Beckman J.A., and Creager M.A. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 166-172
26. Ishizaka N., Ishizaka Y., Takahashi E., Yamakado M., and Hashimoto H. High serum bilirubin level is inversely associated with the presence of carotid plaque. Stroke 32 (2001) 580-583
27. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
28. Yung L.M., Leung F.P., Yao X., Chen Z.Y., and Huang Y. Reactive oxygen species in vascular wall. Cardiovasc. Hematol. Disord. Drug Targets 6 (2006) 1-19
29. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007) 842-857
30. Schönbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58 (2001) 4-43
31. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., and Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4342-4346
32. Denger S., Jahn L., Wende P., et al. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 144 (1999) 15-23
33. Mach F., Schönbeck U., Bonnefoy J.Y., Pober J.S., and Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96 (1997) 396-399
34. Semb A.G., van Wissen S., Ueland T., et al. Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: down regulatory effect of statin therapy. J. Am. Coll. Cardiol. 41 (2003) 275-279
35. Gokulakrishnan K., Deepa R., Mohan V., and Gross M.D. Soluble P selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome-the Chennai Urban Rural Epidemiology Study. Metabolism 55 (2006) 237-242
36. McEver R.P. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 16 (1990) 73-80
37. Tedder T.F., Steeber D.A., Chen A., and Engel P. The selectins: vascular adhesion molecules. FASEB J. 9 (1995) 866-873
38. McEver R.P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J. Cell. Biochem. 45 (1991) 156-161
39. Blann A.D., and Lip G.Y.H. Hypothesis: is soluble P-selectin a new marker of platelet activation?. Atherosclerosis 128 (1997) 135-138
40. Blann A.D., Faragher E.B., and McCollum C.N. Increased soluble P-selectin following myocardial infarction. A new marker for the progression of atherosclerosis. Blood Coagul. Fibrinolysis 8 (1997) 383-390
41. Lindenblatt N., Bordel R., Schareck W., Menger M.D., and Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 601-606
42. Vachharajani T.J., Work J., Issekutz A.C., and Granger D.N. Heme oxygenase modulates selectin expression in different regional vascular beds. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) 1613-1617
43. Hayashi S., Takamiya R., Yamaguchi T., et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85 (1999) 663-671
44. McCarty M.F. "Iatrogenic Gilbert syndrome"-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med. Hypotheses 69 (2007) 974-994
45. Ridker P.M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49 (2007) 2129-2138
46. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension 44 (2004) 6-11
47. Erdogan D., Gullu H., Yildirim E., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184 (2006) 431-437
48. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin. Chem. 46 (2000) 1723-1727
49. Nakagami T., Toyomura K., Kinoshita T., and Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta 1158 (1993) 189-193